Search Details

Word: thomson (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...Kinsley said the moral dilemma over embryonic stem cells is not real and never was. That is not the view of James Thomson, who was the first scientist to isolate human embryonic stem cells and who asserted that "if human embryonic-cell research does not make you a little bit uncomfortable, you have not thought about it enough." Would I be more certain about the lack of moral questions related to this research if I suffered from Parkinson's disease, as Kinsley does? I doubt it. My mother died from the disease, and my brother battles it every...

Author: /time Magazine | Title: Inbox | 12/19/2007 | See Source »

...Best Stocks are the biggest-percentage gainers with a market cap of at least $1 billion on the NYSE or NASDAQ. Data from Thomson Financial

Author: /time Magazine | Title: The 10 Best Stocks | 12/13/2007 | See Source »

...Discomfort in the Lab Michael Kinsley said the moral dilemma over embryonic stem cells is not real and never was [Dec.10]. That is not the view of James Thomson, who was the first scientist to isolate human embryonic stem cells and who observed that "if human embryonic-cell research does not make you a little bit uncomfortable, you have not thought about it enough." Would I be more certain about the lack of moral questions related to this research if I suffered from Parkinson's disease, as Kinsley does? I doubt it. My mother died with the disease...

Author: /time Magazine | Title: Inbox | 12/13/2007 | See Source »

Since CyberKnife was first approved in 1999 for tumor treatment, it has been used in some 40,000 cases, and demand is growing. "We're getting a lot of patients who are self-referring for treatment," says Dr. Euan Thomson, Accuray's CEO. "They're finding out about it through friends who have had treatment, and friends of friends, and they're turning up at their physicians specifically requesting CyberKnife." More than 100 hospitals worldwide have this $4 million robotic radiotherapy system; two-thirds of them are in the U.S. Accuray's order backlog has reached $600 million...

Author: /time Magazine | Title: A Cutting Edge Alternative to Cutting | 12/7/2007 | See Source »

...used to treat solid metastatic tumors most commonly found in the lungs, liver, spine and brain. And the technology is continually evolving. The company's Synchrony program allows doctors to irradiate lung tumors by synchronizing the robotic arm with the rise and fall of a patient's breathing. Says Thomson: "Our dream is that we'll make radiosurgery an option for every cancer patient...

Author: /time Magazine | Title: A Cutting Edge Alternative to Cutting | 12/7/2007 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next